• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Thursday

    3/17/22 12:39:34 PM ET
    $ALLR
    $AVCO
    $BMEA
    $CCEL
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Building operators
    Real Estate
    Get the next $ALLR alert in real time by email

     

     

    Thursday saw 34 companies set new 52-week lows.

    Facts of Interest About Today's 52-Week Lows:

    • SecureWorks (NASDAQ:SCWX) was the largest company by market cap to set a new 52-week low.
    • Allarity Therapeutics (NASDAQ:ALLR) was the smallest company when considering market cap to set a new 52-week low.
    • SecureWorks (NASDAQ:SCWX) was the biggest loser of the morning session, as it dropped 14.17% to reach its new 52-week low.
    • Putnam Master (NYSE:PIM)'s stock made the biggest reversal, trading up 0.0% shortly after dropping to a new 52-week low.

    During Thursday, the following stocks broke to new 52-week lows:

    • DoubleDown Interactive (NASDAQ:DDI) stock achieved a new 52-week low on Thursday morning, hitting $11.64 and moving down 4.08%.
    • Nuvalent (NASDAQ:NUVL) shares set a new yearly low of $11.00 this morning. The stock was down 0.17% on the session.
    • MFS Intermediate IT (NYSE:MIN) shares fell to $3.09 on Thursday, setting a new 52-week low with a shift of down 0.48%.
    • Omega Therapeutics (NASDAQ:OMGA) stock hit a yearly low of $7.10. The stock was up 0.4% for the day.
    • Rallybio (NASDAQ:RLYB) shares hit a yearly low of $8.00. The stock was down 2.42% on the session.
    • Hooker Furnishings (NASDAQ:HOFT) shares reached a new 52-week low of $19.63 on Thursday morning, moving down 0.85%.
    • Willis Lease Finance (NASDAQ:WLFC) stock broke to a new 52-week low of $33.01 on Thursday. Shares of the company traded up 0.39%.
    • Putnam Master (NYSE:PIM) shares set a new 52-week low of $3.41. The stock traded 0.0% (flat).
    • Zenvia (NASDAQ:ZENV) stock dropped to a yearly low on Thursday of $3.73. Shares traded up 5.22%.
    • Biomea Fusion (NASDAQ:BMEA) stock hit a new 52-week low of $5.30. The stock was down 3.79% on the session.
    • Hamilton Beach Brands (NYSE:HBB) stock hit a yearly low of $10.70. The stock was up 1.82% for the day.
    • Werewolf Therapeutics (NASDAQ:HOWL) shares set a new yearly low of $4.29 this morning. The stock was up 0.56% on the session.
    • MFS Government Markets (NYSE:MGF) stock set a new 52-week low of $3.76 on Thursday, moving down 0.27%.
    • Celcuity (NASDAQ:CELC) stock hit $7.72 on Thursday morning, setting a new 52-week low for a change of up 0.88%.
    • Equillium (NASDAQ:EQ) stock broke to a new 52-week low of $3.18 on Thursday. Shares of the company traded up 0.92%.
    • Hill International (NYSE:HIL) shares were down 2.25% for the day, having made a 52-week low of $1.72.
    • Graham (NYSE:GHM) shares set a new yearly low of $7.24 this morning. The stock was up 3.25% on the session.
    • NewAge (NASDAQ:NBEV) shares hit a yearly low of $0.51. The stock was up 0.75% on the session.
    • Retail Value (NYSE:RVI) stock achieved a new 52-week low on Thursday morning, hitting $2.72 and moving down 3.11%.
    • Cryo-Cell International (NASDAQ:CCEL) stock broke to a new 52-week low of $7.25 on Thursday. Shares of the company traded up 0.27%.
    • Qilian Intl Hldg Gr (NASDAQ:QLI) shares fell to $1.50 on Thursday, setting a new 52-week low with a shift of down 3.66%.
    • Avalon Globocare (NASDAQ:AVCO) stock broke to a new 52-week low of $0.59 on Thursday. Shares of the company traded down 2.87%.
    • IN8bio (NASDAQ:INAB) stock drifted down 1.81% on Thursday morning to hit a new 52-week low of $2.44.
    • Very Good Food (NASDAQ:VGFC) shares made a new 52-week low of $0.36 on Thursday. The stock was down 8.73% for the day.
    • Femasys (NASDAQ:FEMY) shares set a new 52-week low of $1.75. The stock traded up 3.69%.
    • Allarity Therapeutics (NASDAQ:ALLR) shares moved down 1.36% on Thursday to hit a new 52-week low of $2.10, drifting down 1.36%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $ALLR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALLR
    $AVCO
    $BMEA
    $CCEL

    CompanyDatePrice TargetRatingAnalyst
    Graham Corporation
    $GHM
    1/27/2026$80.00Outperform → Market Perform
    Northland Capital
    Biomea Fusion Inc.
    $BMEA
    1/13/2026$8.00Buy
    Rodman & Renshaw
    Werewolf Therapeutics Inc.
    $HOWL
    12/19/2025$1.00Outperform → Neutral
    Wedbush
    Celcuity Inc.
    $CELC
    12/12/2025$126.00Overweight
    Wells Fargo
    Nuvalent Inc.
    $NUVL
    11/24/2025Buy
    Truist
    Femasys Inc.
    $FEMY
    11/20/2025$6.50Buy
    Laidlaw
    Celcuity Inc.
    $CELC
    11/18/2025$110.00Outperform
    Wolfe Research
    Celcuity Inc.
    $CELC
    11/17/2025Buy → Neutral
    H.C. Wainwright
    More analyst ratings

    $ALLR
    $AVCO
    $BMEA
    $CCEL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Graham downgraded by Northland Capital with a new price target

    Northland Capital downgraded Graham from Outperform to Market Perform and set a new price target of $80.00

    1/27/26 8:29:26 AM ET
    $GHM
    Industrial Machinery/Components
    Industrials

    Rodman & Renshaw initiated coverage on Biomea Fusion with a new price target

    Rodman & Renshaw initiated coverage of Biomea Fusion with a rating of Buy and set a new price target of $8.00

    1/13/26 10:18:10 AM ET
    $BMEA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Werewolf Therapeutics downgraded by Wedbush with a new price target

    Wedbush downgraded Werewolf Therapeutics from Outperform to Neutral and set a new price target of $1.00

    12/19/25 9:28:37 AM ET
    $HOWL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLR
    $AVCO
    $BMEA
    $CCEL
    SEC Filings

    View All

    SEC Form 8-K filed by IN8bio Inc.

    8-K - IN8BIO, INC. (0001740279) (Filer)

    2/9/26 8:31:05 AM ET
    $INAB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 8-K filed by Werewolf Therapeutics Inc.

    8-K - Werewolf Therapeutics, Inc. (0001785530) (Filer)

    2/6/26 4:41:00 PM ET
    $HOWL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Equillium Inc.

    SCHEDULE 13G/A - Equillium, Inc. (0001746466) (Subject)

    2/6/26 4:32:05 PM ET
    $EQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLR
    $AVCO
    $BMEA
    $CCEL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $ALLR
    $AVCO
    $BMEA
    $CCEL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $ALLR
    $AVCO
    $BMEA
    $CCEL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer

    NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- IN8bio (NASDAQ:INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ ) T cell therapies and T cell engagers for cancer and autoimmune diseases, today announced the promotion of Kate Rochlin, Ph.D., to President and Chief Operating Officer, effective immediately. Dr. Rochlin has served as IN8bio's Chief Operating Officer since December 2021, following her tenure as Vice President and Associate Vice President of Operations and Innovation beginning in August 2020. In her expanded role, she will continue to oversee company operations as IN8bio advances its clinical and preclinical pipeline and prepares for its next

    2/9/26 8:00:00 AM ET
    $INAB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Graham Corporation Reports Third Quarter Fiscal 2026 Results

    Third Quarter Fiscal 2026 Highlights: Revenue increased 21% to $56.7 million Gross profit increased 15% to $13.5 million; Gross profit margin was 23.8% Net income per diluted share increased 79% to $0.25; adjusted net income per diluted share1 increased 72% to $0.31 Adjusted EBITDA1 increased 50% to $6.0 million; Adjusted EBITDA margin1 was 10.7% Orders2 were $71.7 million; Book-to-Bill ratio2 of 1.3x and record backlog2 of $515.6 million Strong balance sheet with no debt, $22.3 million in cash, and access to $43.0 million under its revolving credit facility at quarter end to support growth initiatives Updating and increasing full year fiscal 2026 guidance; Remain on tr

    2/6/26 6:30:00 AM ET
    $GHM
    Industrial Machinery/Components
    Industrials

    Nuvalent to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

    CAMBRIDGE, Mass., Feb. 5, 2026 /PRNewswire/ -- Nuvalent, Inc. (NASDAQ:NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., Chief Executive Officer, and Alexandra Balcom, Chief Financial Officer, will participate in a fireside chat during the Guggenheim Emerging Outlook: Biotech Summit 2026 on Thursday, February 12, 2026, at 1:30 p.m. ET in NYC. A live webcast will be available in the Investors section of Nuvalent's website at www.nuvalent.com,

    2/5/26 6:30:00 AM ET
    $NUVL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by CHIEF FINANCIAL OFFICER Mccall Patrick

    4 - IN8BIO, INC. (0001740279) (Issuer)

    2/6/26 4:30:26 PM ET
    $INAB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by President and COO Rochlin Kate

    4 - IN8BIO, INC. (0001740279) (Issuer)

    2/6/26 4:30:23 PM ET
    $INAB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by EVP and CSO Lamb Lawrence

    4 - IN8BIO, INC. (0001740279) (Issuer)

    2/6/26 4:30:27 PM ET
    $INAB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Officer Erdtmann Rainer M bought $42,999 worth of shares (30,000 units at $1.43), increasing direct ownership by 4% to 723,027 units (SEC Form 4)

    4 - Biomea Fusion, Inc. (0001840439) (Issuer)

    12/15/25 4:15:04 PM ET
    $BMEA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Interim CEO Hitchcock Michael J.M. bought $99,180 worth of shares (100,000 units at $0.99), increasing direct ownership by 667% to 115,000 units (SEC Form 4)

    4 - Biomea Fusion, Inc. (0001840439) (Issuer)

    12/4/25 4:15:03 PM ET
    $BMEA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Officer Erdtmann Rainer M bought $54,552 worth of shares (50,000 units at $1.09), increasing direct ownership by 8% to 693,027 units (SEC Form 4)

    4 - Biomea Fusion, Inc. (0001840439) (Issuer)

    12/2/25 4:15:02 PM ET
    $BMEA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLR
    $AVCO
    $BMEA
    $CCEL
    Financials

    Live finance-specific insights

    View All

    Graham Corporation Reports Third Quarter Fiscal 2026 Results

    Third Quarter Fiscal 2026 Highlights: Revenue increased 21% to $56.7 million Gross profit increased 15% to $13.5 million; Gross profit margin was 23.8% Net income per diluted share increased 79% to $0.25; adjusted net income per diluted share1 increased 72% to $0.31 Adjusted EBITDA1 increased 50% to $6.0 million; Adjusted EBITDA margin1 was 10.7% Orders2 were $71.7 million; Book-to-Bill ratio2 of 1.3x and record backlog2 of $515.6 million Strong balance sheet with no debt, $22.3 million in cash, and access to $43.0 million under its revolving credit facility at quarter end to support growth initiatives Updating and increasing full year fiscal 2026 guidance; Remain on tr

    2/6/26 6:30:00 AM ET
    $GHM
    Industrial Machinery/Components
    Industrials

    MFS Announces Closed-End Fund Distributions

    MFS Investment Management® (MFS®) announced today monthly distributions of the following closed-end funds, all with declaration dates of February 2, 2026, ex-dividend dates of February 17, 2026, record dates of February 17, 2026, and payable dates of February 27, 2026: Fund (ticker) Income/Share Other Sources/Share* Total Amount/Share MFS® Charter Income Trust (NYSE:MCR)^ $0.0000 $0.044950 $0.044950 MFS® Government Markets Income Trust (NYSE:MGF)^ $0.0000 $0.019060 $0.019060 MFS® High Income Municipal Trust (NYSE:CXE) $0.0180 $0.0000 $0.0180 MFS® High Yield Municipal Trust

    2/2/26 4:15:00 PM ET
    $CIF
    $CMU
    $CXE
    Trusts Except Educational Religious and Charitable
    Finance
    Investment Managers
    Finance Companies

    DoubleDown Interactive to Report 2025 Fourth Quarter Results on February 11 and Host Conference Call and Webcast

    SEOUL, South Korea, Jan. 28, 2026 (GLOBE NEWSWIRE) -- DoubleDown Interactive Co., Ltd. (NASDAQ:DDI) ("DoubleDown" or the "Company"), a leading developer and publisher of digital games on mobile and web-based platforms, announced today that it will release its 2025 fourth quarter financial results after the market closes on Wednesday, February 11, 2026, and host a conference call and simultaneous webcast at 5:00 p.m. ET (2:00 p.m. PT) that day. Both the call and webcast are open to the general public. On the call, DoubleDown management will review the Company's financial results and provide a business update, followed by a question-and-answer session. To access the call, please use the fol

    1/28/26 7:00:00 AM ET
    $DDI
    EDP Services
    Technology

    $ALLR
    $AVCO
    $BMEA
    $CCEL
    Leadership Updates

    Live Leadership Updates

    View All

    Willis Lease Finance Corporation Welcomes Steven Bridgland as Head of Investor Relations & Capital Markets for Willis Aviation Capital

    COCONUT CREEK, Fla., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ:WLFC) ("WLFC" or the "Company"), the leading lessor of commercial aircraft engines and a global provider of aviation services, today announced the appointment of Steven Bridgland as Head of Investor Relations & Capital Markets for its recently announced asset manager, Willis Aviation Capital. In this role, Steve will lead day-to-day management of Willis Aviation Capital's existing investor relationships, continue development of new investor relationships and support capital deployment efforts. With more than three decades of experience, Steve brings extensive expertise in equity and debt capita

    1/22/26 8:25:00 AM ET
    $WLFC
    Industrial Specialties
    Consumer Discretionary

    Hooker Furnishings to Appoint New Independent Director with Industry Expertise

    Enters Cooperation Agreement with GVIC Announces Retirement of Board Chair Chris Beeler at 2026 Annual Meeting Following 33 Years of Service to Hooker MARTINSVILLE, Va., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Hooker Furnishings Corporation (NASDAQ-GS: HOFT) ("Hooker" or the "Company"), a global leader in home furnishings, today announced it has entered into a cooperation agreement (the "Agreement") with Global Value Investment Corporation ("GVIC") under which GVIC and the Company will work together in good faith to identify a mutually agreeable independent director with industry expertise within 45 days of signing the Agreement. Once the agreed upon director is identified and properly vetted,

    1/2/26 4:01:00 PM ET
    $HOFT
    Home Furnishings
    Consumer Discretionary

    Nuvalent Appoints Ron Squarer to Board of Directors

    CAMBRIDGE, Mass., Dec. 10, 2025 /PRNewswire/ -- Nuvalent, Inc. (NASDAQ:NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the appointment of Ron Squarer to its Board of Directors. "We welcome Ron to our Board of Directors, where his personal dedication to advancing oncology therapeutics, demonstrated success in evolving research and development organizations to fully integrated businesses, and proven global commercial acumen will strengthen and sharpen our pre-launch

    12/10/25 4:01:00 PM ET
    $NUVL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLR
    $AVCO
    $BMEA
    $CCEL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Hamilton Beach Brands Holding Company

    SC 13D/A - Hamilton Beach Brands Holding Co (0001709164) (Subject)

    12/10/24 5:37:18 PM ET
    $HBB
    Home Furnishings
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Hamilton Beach Brands Holding Company

    SC 13D/A - Hamilton Beach Brands Holding Co (0001709164) (Subject)

    12/10/24 5:25:19 PM ET
    $HBB
    Home Furnishings
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by SecureWorks Corp.

    SC 13G/A - SecureWorks Corp (0001468666) (Subject)

    12/6/24 3:33:53 PM ET
    $SCWX
    Computer Software: Prepackaged Software
    Technology